Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 108.32
-1.85 (-1.68%)
Sep 11, 2025, 3:30 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 10.12 billion as of September 11, 2025. Its market cap has increased by 25.81% in one year.
Market Cap
10.12B
Enterprise Value
5.86B
Revenue
5.67B
Ranking
n/a
PE Ratio
3.44
Stock Price
108.32
Market Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 10.12B, an increase of 8,978.47%. That is a compound annual growth rate of 18.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 10.30B | 60.51% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | 3.68B | 230.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,823.10B |
| Divi's Laboratories | 1,601.17B |
| Cipla | 1,260.74B |
| Apollo Hospitals Enterprise | 1,140.07B |
| Mankind Pharma | 1,072.76B |
| Zydus Lifesciences | 1,046.08B |
| Fortis Healthcare | 729.25B |
| Alkem Laboratories | 644.87B |